On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Dallas. We completed any pending result uploads and resumed scheduled result uploads. Congratulations on this important success!
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...